FineMark National Bank & Trust’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-9,814
| Closed | -$975K | – | 400 |
|
|
2019
Q3 | $975K | Sell |
9,814
-1,156
| -11% | -$110K | 0.05% | 178 |
|
|
2019
Q2 | $1.01M | Sell |
10,970
-40,578
| -79% | -$3.85M | 0.06% | 169 |
|
|
2019
Q1 | $4.86M | Buy |
51,548
+5,194
| +11% | +$454K | 0.28% | 82 |
|
|
2018
Q4 | $2.97M | Buy |
46,354
+36,675
| +379% | +$2.71M | 0.2% | 96 |
|
|
2018
Q3 | $866K | Sell |
9,679
-4,110
| -30% | -$363K | 0.05% | 172 |
|
|
2018
Q2 | $1.09M | Sell |
13,789
-1,349
| -9% | -$112K | 0.07% | 165 |
|
|
2018
Q1 | $1.35M | Sell |
15,138
-420
| -3% | -$40.3K | 0.09% | 141 |
|
|
2017
Q4 | $1.62M | Buy |
15,558
+2,047
| +15% | +$231K | 0.1% | 131 |
|
|
2017
Q3 | $1.97M | Sell |
13,511
-253
| -2% | -$34.5K | 0.13% | 120 |
|
|
2017
Q2 | $1.79M | Buy |
13,764
+218
| +2% | +$26.7K | 0.13% | 122 |
|
|
2017
Q1 | $1.69M | Buy |
13,546
+450
| +3% | +$53.9K | 0.12% | 126 |
|
|
2016
Q4 | $1.52M | Sell |
13,096
-166
| -1% | -$18.5K | 0.12% | 127 |
|
|
2016
Q3 | $1.39M | Sell |
13,262
-2,218
| -14% | -$240K | 0.15% | 130 |
|
|
2016
Q2 | $1.53M | Sell |
15,480
-444
| -3% | -$45.9K | 0.17% | 119 |
|
|
2016
Q1 | $1.59M | Sell |
15,924
-315
| -2% | -$32.4K | 0.19% | 113 |
|
|
2015
Q4 | $1.94M | Buy |
16,239
+480
| +3% | +$55.5K | 0.23% | 108 |
|
|
2015
Q3 | $1.71M | Buy |
15,759
+390
| +3% | +$48.4K | 0.23% | 108 |
|
|
2015
Q2 | $1.78M | Sell |
15,369
-1,453
| -9% | -$166K | 0.23% | 105 |
|
|
2015
Q1 | $1.94M | Sell |
16,822
-155
| -0.9% | -$18.5K | 0.26% | 103 |
|
|
2014
Q4 | $1.9M | Buy |
16,977
+37
| +0.2% | +$3.9K | 0.28% | 98 |
|
|
2014
Q3 | $1.61M | Buy |
16,940
+312
| +2% | +$28.2K | 0.26% | 108 |
|
|
2014
Q2 | $1.43M | Sell |
16,628
-764
| -4% | -$58.1K | 0.24% | 112 |
|
|
2014
Q1 | $1.21M | Sell |
17,392
-3,718
| -18% | -$294K | 0.23% | 115 |
|
|
2013
Q4 | $1.78M | Buy |
21,110
+1,316
| +7% | +$104K | 0.37% | 74 |
|
|
2013
Q3 | $1.52M | Buy |
19,794
+2,246
| +13% | +$157K | 0.38% | 67 |
|
|
2013
Q2 | $1.03M | Buy |
+17,548
| New | +$1.06M | 0.31% | 67 |
|
Other funds holding CELG
FP
HCM
PCMC
WCG
FineMark National Bank & Trust's CELG Position: Q4 2019 in Review
FineMark National Bank & Trust sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 9,814 shares — an estimated $975K sold.
FineMark National Bank & Trust first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $4.86M in Q1 2019. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.
- FineMark National Bank & Trust reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
- FineMark National Bank & Trust sold 9,814 Celgene Corp shares in Q4 2019, an estimated $975K.
- FineMark National Bank & Trust first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
- FineMark National Bank & Trust's Celgene Corp position peaked at $4.86M in Q1 2019.
- 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.
Based on FineMark National Bank & Trust's 13F filing for Q4 2019, filed 7 Feb 2020.